After Kranus Health completed its Series A round in June 2022 with 6.1 million euros (6.5 million dollars), last autumn a first increase to 14.3 million euros (15 million dollars). The Munich-based healthtech company has now increased its financing to a total of 18.4 million euros (20 million dollars).
The new capital increase of €4.6 million ($5 million) was led by French VCs Caphorn and Future Positive Capital. The French investment is no coincidence: Kranus Health entered the French market in July 2023.
The additional capital will be used for further expansion in Europe and the USA and the expansion of its urological treatment offerings. The company recently expanded its treatment spectrum to include the treatment of BPH (benign prostatic hyperplasia) and Incontinence in women The startup is also developing a virtual therapy for prostate cancer.
"This financing round is another major success for us. The reason for the strong market interest is our rapid growth over the past year and the promising prospects for entering new international markets. I am very pleased to be working with Caphorn and Future Positive Capital, two France-based VC funds with global ambitions, which will further diversify our investment community,"
says Jens Nörtershäuser, Founder and Co-CEO of Kranus Health.
Kranus Health focuses on direct sales
"A cornerstone of our strategy from day one has been a strong focus on physician sales and the development of our own sales team. Our goal is to further expand our field sales force, expand our involvement with physicians in private practice, and thus extend our reach,"
explained Thilo Kleinschmidt, Co-founder and Co-CEO.
The startup focuses on urology specialists to raise their awareness of digital treatment options in the field of urology. To reach general practitioners, it has a distribution partnership with the German pharmaceutical company Pohl-Boskamp.
Kranus Health currently reports working with over 1,000 prescribing urologists, treating over 10,000 patients. This number is expected to triple by 2024.
